January 16, 2017 11:07 AM ET

Biotechnology

Company Overview of KaloBios Pharmaceuticals, Inc.

Key Executives for KaloBios Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Cameron Durrant M.D., MBA58 RelationshipsChairman of the Board, Chief Executive Officer, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee56
David L. Tousley M.B.A., CPA11 RelationshipsInterim Chief Financial Officer60
Charles J. Democko No RelationshipsSenior Vice President of Regulatory Affairs and Quality61

KaloBios Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Cameron Durrant M.D., MBA 58 RelationshipsKaloBios Pharmaceuticals, Inc.56
James W. Larrick M.D., Ph.D. 39 RelationshipsKaloBios Pharmaceuticals, Inc.--
Ronald Barliant J.D. 5 RelationshipsKaloBios Pharmaceuticals, Inc.71
Timothy Morris 5 RelationshipsKaloBios Pharmaceuticals, Inc.54
Dale Chappell M.D. 5 RelationshipsBlack Horse Capital Advisors LLC46
View All Board Members

KaloBios Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Timothy Morris5 Relationships3 Executives
Compensation Committee M.D., MBACameron Durrant58 Relationships2 Executives
Nominating Committee J.D.Ronald Barliant5 Relationships2 Executives
Corporate Governance Committee J.D.Ronald Barliant5 Relationships2 Executives
Advisory Board M.D., Ph.D.James W. Larrick39 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
369.6K
Bonus
253.9K
Total Short Term Compensation
462.2K
Total Value of Options
34.4M
Compensation as of Fiscal Year
KaloBios Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

InMed Pharmaceuticals Inc. Appoints Martin Bott to the Board of Directors
January 13, 2017 8:42 PM ET
Uni-Bio Science Group Limited Announces Executive Changes
January 13, 2017 11:38 AM ET
Bioscience Americas, LLC Appoints Shekhar K. Challa to Its Board of Advisors
January 13, 2017 11:30 AM ET
Nivalis Therapeutics, Inc. Announces Management Changes, with Effect from January 15, 2017
January 12, 2017 9:16 PM ET
Immunomedics, Inc. Announces Board Changes
January 12, 2017 9:06 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KaloBios Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.